Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.

228.97 2.53 −1.09%
Market cap
$162.7B
P/E
40.5×
Fwd P/E
29.2×
Dividend yield
0.66%
F-score
6/9
Altman Z
4.52
Beneish M
−2.57
Dividend safety
69/100

Danaher Corporation (DHR) EPS (diluted)

Alert me on EPS (diluted)

Danaher Corporation's EPS (diluted) for fiscal 2025 was $5.05, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $5.63. Over the past ten years it has ranged from $3.53 (fiscal 2017) to $9.66 (fiscal 2022); the current reading is higher than 64% of that period. EPS (diluted) has fallen for 3 consecutive fiscal years. Danaher Corporation ranks 9th of 52 Diagnostics & Research companies by EPS (diluted).

EPS (diluted), annual

Embed this chart

Annual newest first

Period EPS (diluted) Change
FY2025 $5.05 (4.54%)
FY2024 $5.29 (17.08%)
FY2023 $6.38 (33.95%)
FY2022 $9.66 12.20%
FY2021 $8.61 76.07%
FY2020 $4.89 20.74%
FY2019 $4.05 8.29%
FY2018 $3.74 5.95%
FY2017 $3.53 (3.29%)
FY2016 $3.65 (23.00%)

Quarterly newest first

Period EPS (diluted) Change
Jun 2026 $1.23 (15.17%)
Mar 2026 $1.45 (13.69%)
Dec 2025 $1.68 32.28%
Sep 2025 $1.27 64.94%
42 more quarters

Against its own ten years

Low $3.53 High $9.66
Ten-year median $4.89
Current reading's percentile 64

EPS (diluted) against peers

What EPS (diluted) is

Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.

Reported line item

The full definition of EPS (diluted) →

More on DHR